Abstract
Antidepressants, as the name implies, are drugs used to treat depression and are widely used therapeutic agents. They are also some of the most frequently encountered drugs in forensic and clinical toxicology. Antidepressants are often characterized based on when they were developed: first-generation antidepressants, second-generation antidepressants, selective serotonin reuptake inhibitors, and third-generation antidepressants. All of the antidepressants are well absorbed and reach peak serum concentrations within 2–12 h, but there is considerable first-pass metabolism with most of these drugs. They are rather lipophilic and have large volumes of distribution. In general, these drugs are extensively metabolized by cytochrome P450 isoenzymes to demethylated and hydroxylated metabolites, many of which are active. Analysis of these compounds in biological specimens requires specimen preparation either by liquid–liquid extraction or solid-phase extraction. Chromatographic separation by gas or liquid chromatography allows simultaneous analysis of most antidepressants and their major metabolites. First-generation antidepressants are associated with greater toxicity, primarily due to anticholinergic effects, central nervous system effects, and cardiovascular effects. Interpretation of postmortem concentrations of these drugs is complicated by postmortem redistribution; therefore, the use of therapeutic ranges established for antemortem serum is inappropriate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Apter JT, Greenberg WM (1994) New drug development in psychiatry. J Clin Res Drug Dev 8:87–100
Balant-Gorgia AE, Balant LP (1992) Therapeutic drug monitoring of antidepressants. Clin Ther 14(4):612–614
Cole JO, Bodkin JA (1990) Antidepressant drug side effects. J Clin Psychiatry 51(suppl):21–26
Devane CL (1987) Monitoring cyclic antidepressants. Clin Lab Med 7(3):551–566
Devane CL (1994) Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 97(6A):13S–23S
Duman RS, Heninger GR, Nestler EJ (1977) A molecular and cellular theory of depression. Arch Gen Psychiatry 54(7):597–606
Ereshefsky L, Riesenman C, Lam YWF (1996) Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system. J Clin Psychiatry 57(suppl 8):17–25
Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17(suppl 1):2S–8S
Furlanut M, Benetello P, Spina E (1993) Pharmacokinetic optimisation of tricyclic antidepressant therapy. Clin Pharmacokinet 24(4):301–318
Hebb JH, Caplan YH, Crooks CR, Mergner WJ (1982) Blood and tissue concentrations of tricyclic antidepressant drugs in postmortem cases: literature survey and a study of forty deaths. J Anal Toxicol 6:209–216
Hyman SE, Nestler EJ (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153(2):151–162
Jones GR, Pounder DJ (1987) Site dependence of drug concentrations in postmortem blood—a case study. J Anal Toxicol 11:184–190
Joron S, Rogert H (1994) Simultaneous determination of antidepressant drugs and metabolites by HPLC. Design and validation of a simple and reliable analytical procedure. Biomed Chromatogr 8(4):158–164
McIntyre IM, King CV, Skafidis S, Drummer OH (1993) Dual ultraviolet wavelength high-performance liquid chromatographic method for the forensic or clinical analysis of seventeen antidepressants and some selected metabolites. J Chromatogr 621(2):215–223
Nemeroff CB, Devane CL, Pollock BG (1996) Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153(3):311–320
O’Toole SM, Johnson DA (1997) Psychobiology and psychopharmacotherapy of unipolar major depression; a review. Arch Psychiatr Nurs 6:304–313
Owens MJ (1996) Molecular and cellular mechanisms of antidepressant drugs. Depress Anxiety 4:153–159
Preskorn SH (1997) Clinically relevant pharmacology of selective serotonin reuptake inhibitors. Clin Pharmacokinet 32(suppl 1):1–21
Preskorn SH (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 54(suppl:14–34):55–56
Prouty RW, Anderson WH (1990) The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 35(2):243–270
Richelson E (1997) Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 72:835–847
Stahl SM (1998) Basic psychopharmacology of antidepressants, Part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59(suppl 4):5–14
Spina E, Santoro V, D’Arrigo C (2008) Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants—a review. Clin Ther 30(7):1206–1227
Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F (1997) Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci 42(2):335–339
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Anderson, W.H. (2020). Antidepressants. In: Levine, B.S., KERRIGAN, S. (eds) Principles of Forensic Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-030-42917-1_27
Download citation
DOI: https://doi.org/10.1007/978-3-030-42917-1_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42916-4
Online ISBN: 978-3-030-42917-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)